(Georgetown University Medical Center) The field of personalized cancer research and treatment grows with each day.
And a new collaboration with Washington's largest biomedical research organization and an international research and biobanking company is contributing to that growth.Georgetown University Medical Center announced today an agreement with Indivumed GmbH, based in Hamburg, Germany, which provides the foundation for the analysis of complex clinical molecular signatures from cancer patients, enabling researchers and physicians to better diagnose and tailor cancer treatments for individual patients.
Post new comment